Retrieve available abstracts of 10 articles: HTML format
Single Articles
June 2025
MROZ K, Paszek E, Polak M, Undas A, et al Prothrombotic fibrin clot phenotype as a risk factor for persistent left
ventricular thrombus following acute myocardial infarction.
J Thromb Haemost. 2025 Jun 10:S1538-7836(25)00361. PubMedAbstract available
VAN EDOM CJ, Fiorelli F, Balthazar T, Monteagudo-Vela M, et al Discrepancy between parallel anti-Xa and activated partial thromboplastin time is
related to mortality in patients with Impella-supported cardiogenic shock.
J Thromb Haemost. 2025;23:1810-1816. PubMedAbstract available
MOUSSA MD, Abou-Arab O, Staessens S, Jungling M, et al Comparison of the effects of phosphorylcholin versus heparin-based surface
coating on clinical and histologic outcomes during veno-arterial extracorporeal
membrane oxygenation support: a propensity score weighted analysis.
J Thromb Haemost. 2025;23:1879-1892. PubMedAbstract available
April 2025
ARIENS RA, McPherson HR, De Simone I, Huskens D, et al Length of ischaemia duration is associated with fibrin film coverage of acute
myocardial infarction thrombi.
J Thromb Haemost. 2025 Apr 24:S1538-7836(25)00266. PubMedAbstract available
January 2025
CHEN X, Liao X, Lu G, Ma Y, et al Aptamer BT200 is protective against myocardial ischemia-reperfusion injury in
mice.
J Thromb Haemost. 2025;23:222-234. PubMedAbstract available
December 2024
SUNDBOLL J, Veres K, Troelsen FS, Wurtz M, et al Myocardial infarction and short- or long-term risk of a subsequent cancer
diagnosis: A Danish Nationwide Cohort Study.
J Thromb Haemost. 2024 Dec 17:S1538-7836(24)00728. PubMedAbstract available
November 2024
POLZIN A, Benkhoff M, Thienel M, Barcik M, et al Long-term FXa inhibition attenuates thromboinflammation after acute myocardial
infarction and stroke by platelet proteome alteration.
J Thromb Haemost. 2024 Nov 15:S1538-7836(24)00641. PubMedAbstract available
October 2024
VALERIANI E, Pannunzio A, Palumbo IM, Bartimoccia S, et al Risk of venous thromboembolism and arterial events in patients with
hypoalbuminemia: a comprehensive meta-analysis of more than 2 million patients.
J Thromb Haemost. 2024;22:2823-2833. PubMedAbstract available
August 2024
DOUKETIS JD, Yi Q, Bhatt DL, Muehlhofer E, et al Perioperative management and outcomes in patients receiving low-dose rivaroxaban
and/or aspirin: a subanalysis of the Cardiovascular Outcomes for People Using
Anticoagulation Strategies (COMPASS) trial.
J Thromb Haemost. 2024;22:2227-2233. PubMedAbstract available
May 2024
POCOCK SJ, Owen R, Gregson J, Mt-Isa S, et al Quantifying the benefit-risk trade-off for individual patients in a clinical
trial: principles and antithrombotic case study.
J Thromb Haemost. 2024;22:1399-1409. PubMedAbstract available